All Articles

4 ARTICLES TAGGED "LIFE SCIENCES"

OpenAI's Bio-Tech Revolution: The Orchestra Bio Acquisition and Life Sciences Shift in 2024

OpenAI is shifting its focus toward life sciences through the strategic acquisition of Orchestra Bio. This move aims to accelerate the journey from lab research to clinical treatments using advanced AI agents, potentially revolutionizing how we develop medicine.

5 min readRead →

AI Newsai newsnews6d ago

OpenAI Rosalind: Transforming Drug Discovery in 2026 with Orchestra Bio Acquisition

OpenAI has acquired Orchestra Bio to launch Project Rosalind, a major leap in AI-driven drug discovery. This strategic move aims to transform life sciences research by streamlining complex biological data.

12 min readRead →

AI Newsai newsnewsSep 17, 2026

AI in Life Sciences: Inside the $2B Race for AI-Driven Drug Discovery in 2024

OpenAI researcher Miles Wang is in talks to launch a specialized AI startup focused on drug discovery. The $2B valuation underscores the massive potential for AI to revolutionize the pharmaceutical industry by accelerating research and clinical breakthroughs.

4 min readRead →

AI Newsai newsnewsApr 17, 2026

GPT-Rosalind vs GPT-5.4-Cyber: OpenAI's Specialized Frontier AI Models of 2026

OpenAI has introduced GPT-Rosalind for specialized research in drug discovery and genomics, alongside GPT-5.4-Cyber, a model dedicated to strengthening global cybersecurity infrastructure through API grants and trusted access.

8 min readRead →